Enterococcus intestinal domination is associated with increased mortality in the acute leukemia chemotherapy population Journal Article


Authors: Messina, J. A.; Tan, Chin Y.; Ren, Y.; Hill, L.; Bush, A.; Lew, M.; Andermann, T.; Peled, J. U.; Gomes, A.; van den Brink, M. R M.; Chao, N. J.; Surana, N. K.; Sung, A. D.
Article Title: Enterococcus intestinal domination is associated with increased mortality in the acute leukemia chemotherapy population
Abstract: Background Enterococcus intestinal domination (EID), a state of dysbiosis wherein enterococci comprise ≥30% abundance within the microbiota, has been associated with Enterococcus bacteremia, graft-versus-host disease, and mortality in the allogeneic hematopoietic stem cell transplant (allo HCT) population. The acute leukemia (AL) chemotherapy population includes patients receiving intensive chemotherapy, but not all patients go on to have an allo HCT. The impact of EID on outcomes including mortality in the AL chemotherapy population is unknown. Methods Microbiota composition from weekly stool samples was analyzed using 16S ribosomal RNA gene sequencing. Patients were analyzed in 2 cohorts: AL chemotherapy cohort and allo HCT cohort. α -diversity and richness were calculated. Kaplan-Meier analysis was used to analyze mortality. Results A total of 929 stool samples were collected from 139 patients. Both allo HCT and AL cohorts had a decline in α-diversity and richness over the course of treatment that tended not to return to baseline months later. EID was observed in at least 1 sample in 36% of allo HCT patients and 49% of AL patients. Patients with observed EID had lower α-diversity over time. Similar to the HCT cohort, AL patients with EID had reduced overall survival. We identified 4 other genera that were commonly found in ≥30% relative abundance within the microbiota, but none were associated with mortality. In fact, in allo HCT, Bacteroides abundance ≥30% was associated with improved survival. Conclusions EID is associated with increased all-cause mortality in HCT and AL cohorts. Unlike EID, relative abundance ≥30% by other genera is not associated with increased all-cause mortality.
Keywords: adult; overall survival; sequence analysis; prospective studies; hematopoietic stem cell transplantation; rna; enterococcus; genetic techniques; funding source; middle age; kaplan-meier estimator; chemotherapy, cancer; treatment outcomes -- evaluation; feces -- analysis; human; male; female; leukemia -- drug therapy; acute disease -- drug therapy; leukemia -- mortality; gut microbiota -- adverse effects; gut microbiota -- microbiology; leukemia -- microbiology
Journal Title: Clinical Infectious Diseases
Volume: 78
Issue: 2
ISSN: 1058-4838
Publisher: Oxford University Press  
Date Published: 2024-02-15
Start Page: 414
End Page: 422
Language: English
DOI: 10.1093/cid/ciab1043
PROVIDER: EBSCOhost
PROVIDER: cinahl
PMCID: PMC10874263
PUBMED: 34928341
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan U Peled
    155 Peled
  2. Antonio LC Gomes
    47 Gomes